EHS
EHS

Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status


Lancet Diabetes Endocrinol. 2022 Nov 10:S2213-8587(22)00313-8. doi: 10.1016/S2213-8587(22)00313-8. Online ahead of print.

NO ABSTRACT

PMID:36372068 | DOI:10.1016/S2213-8587(22)00313-8



Source link

EHS
Back to top button